Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(13R,15S)-13-methyl-16-oxa-8,9,12,22,24-pentaazahexacyclo[15.6.2.1^6,9^.1^12,15^.0^2,7^.0^21,25^]heptacosa-1(24),2,4,6,17(25),18,20-heptaene-23,26-dione
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is an experimental small molecule belonging to the class of quinoxalines—organic compounds containing a quinoxaline moiety characterized by a bicyclic structure with nitrogen atoms at positions 1 and 4 of the benzene ring[1]. It is identified in DrugBank as DB06888 and has demonstrated potent inhibitory activity against cyclin-dependent kinase 2 (CDK2) with an IC50 value of 3.4 nM[1]. CDK2 is a serine/threonine protein kinase involved in cell cycle regulation; thus this compound may have potential as an antineoplastic or cell cycle modulator agent through ATP binding inhibition at CDK2.
- Other names
- DB06888DB-06888DB 06888
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on (13R,15S)-13-methyl-16-oxa-8,9,12,22,24-pentaazahexacyclo[15.6.2.1^6,9^.1^12,15^.0^2,7^.0^21,25^]heptacosa-1(24),2,4,6,17(25),18,20-heptaene-23,26-dione.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (13R,15S)-13-methyl-16-oxa-8,9,12,22,24-pentaazahexacyclo[15.6.2.1^6,9^.1^12,15^.0^2,7^.0^21,25^]heptacosa-1(24),2,4,6,17(25),18,20-heptaene-23,26-dione.